SGNL - Signal Genetics, Inc.

Signal Genetics, Inc. (SGNL) is a publicly traded medical diagnostic and genetic testing company based in Carlsbad, California. The company provides services to oncologists and other medical professionals to help them better understand and treat their patients' cancers.

Signal Genetics uses proprietary technology to analyze patients' genetic data and provide personalized recommendations on treatment options. The company also offers comprehensive diagnostic testing services for leukemia, lymphoma, and other blood cancers.

In addition to its medical services, Signal Genetics has also developed a suite of bioinformatics tools that can be used to analyze and interpret large datasets of genetic information. These tools can be used in a variety of research and development applications, including drug discovery and development.

Signal Genetics was founded in 2010 and became a publicly traded company in 2014. The company has partnerships with several major pharmaceutical companies and has received numerous awards and accolades for its innovative technology and services.